GOSS
GOSS
US38341P1021
Gossamer Bio, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 48.471.000 114.701.000
57.7%
Cost of Revenue -- --
--
Gross Profit -- --
--
211.724.000 174.620.000
21.2%
Operating Income -163.253.000 -59.919.000
172.5%
Pretax Income -170.458.000 -55.635.000
206.4%
Net Income Common Stockholders -170.370.000 -56.528.000
201.4%
-- --
--
-- --
--
ende